Comparison of incidence of invasive Streptococcus pneumonioe disease among children before and after introduction of conjugated pneumococcal vaccine

Pediatric Infectious Disease Journal

Volumn 24, Issue 4, 2005, Pages 320-323

  Haddy, Richard I ^a   Perry, Kelvin ^a   Chacko, Chris E ^a   Helton, William B ^a   Bowling, Mark G ^a   Looney, Stephen W ^a,b   Buck, George E ^a  

^a University of Louisville School of Medicine   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Invasive; Pediatrics; Pneumococcus; Vaccine

Indexed keywords

PENICILLIN G; PNEUMOCOCCUS VACCINE;

AGE DISTRIBUTION; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM CULTURE; BLOOD ANALYSIS; CEREBROSPINAL FLUID; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MENINGITIS; MICROBIOLOGY; PENICILLIN RESISTANCE; PLEURA FLUID; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SEX ROLE; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS PNEUMONIA; UNITED STATES; WINTER;

ADOLESCENT; BACTEREMIA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; KENTUCKY; MALE; MENINGITIS, PNEUMOCOCCAL; MENINGOCOCCAL VACCINES; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 17144422083     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000157090.40719.9b     Document Type: Article

References (12)

1. Gunn VL, Nechyba C, eds. The Harriet Lane Handbook: A Manual for Pediatric House Officers. 16th ed. Philadelphia, PA: Mosby; 2002.
2. Black S, Shinefeld H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J. 2000;19:187-195.
3. Clanton M. Pneumococcal disease in United States children: prevalence and treatment. Int J Clin Pract Suppl. 2001;(118):13-21.
4. Black S, Shinefeld H, Baxter R, et al. Post licensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatr Infect Dis J. 2004;23:485-489.
5. Lin PL, Michaels MG, Janosky J, Michelene O, Wald ER, Mason EO. Incidence of invasive pneumococcal disease in children 3 to 36 months of age at a tertiary care pediatric center 2 years after licensure of the pneumococcal conjugate vaccine. Pediatrics. 2003;111:896-899.
6. Eskola J, Takala AK, Kela D, Pakkanen E, Kalliekoski R, Leinonen M. Epidemiology of invasive pneumococcal infections in children in Finland. JAMA. 1992;268:3323-3327.
7. Sheifele D, Halparin S, Pelletier L, Talbot J. Invasive pneumococcal infections in Canadian children, 1991-1998: implications for new vaccination strategies. Clin Infect Dis. 2000;31:58-64.
8. Davis CWC, McIntyre PB. Invasive pneumococcal infection in children, 1981-92: a hospital-based study. J Paediatr Child Health. 1995;31:317-322.
9. Dagan R, Englehard D, Piccard E. Epidemiology of invasive childhood pneumococcal infections in Israel. JAMA. 1992;268:3328-3332.
10. Haddy RI, Klimberg S, Epting RJ. A two-center review of bacteremia in the community hospital. J Fam Pract. 1987;24:253-259.
11. Bennett NM, Buffington J, LaForce FM. Pneumococcal bacteremia in Monroe County, New York. Am J Public Health. 1992;82:1513-1516.
12. Levine MM, Lagos R, Levine OS, et al. Epidemiology of invasive pneumococcal infections in infants and young children in metropolitan Santiago, Chile, a newly industrializing country. Pediatr Infect Dis J. 1998;17:287-293.